Table 3.
Annexin | Benign | Loc-PCA* | Met-PCA† | PCA/MET | P value‡ | |||
---|---|---|---|---|---|---|---|---|
Count | Median n | Count | Median n | Count | Median n | |||
1 | 37 | 2.59 | 360 | 2.45 | 162 | 1.46 | 1.68 | < 0.001 |
2 | 57 | 3.95 | 82 | 3.62 | 214 | 1.47 | 2.46 | < 0.001 |
4 | 23 | 3.65 | 357 | 3.96 | 141 | 1.57 | 2.52 | < 0.001 |
7 | 26 | 3.77 | 350 | 3.97 | 126 | 1.32 | 3.01 | < 0.001 |
11 | 23 | 4.00 | 360 | 3.99 | 163 | 1.30 | 3.01 | < 0.001 |
*Loc-PCA, localized prostate cancer.
†Met-PCA, metastatic hormone refractory prostatic cancer.
‡Kruskal Wallis Test.